SMPD1 and depressive symptom measurement: Concerning the association of ASM activity with depression severity previously reported for the lysosomal enzyme [16] and a major criterion for the utility as a biomarker, we observed a positive correlation of S-ASM activities with BDI-II and MADRS scores, albeit exclusively in the subgroup of patients with remitted MDD and with scores in the range of no clinical depression.